Pallas Health · Modern weight care
Weight loss that works with your biology.
Licensed providers. Compounded semaglutide and tirzepatide, prescribed when clinically appropriate and shipped from US pharmacies.
Brand-name GLP-1 trials · 68 weeks
15–20%
Average body-weight reduction reported in 68-week clinical trials of FDA-approved semaglutide and tirzepatide products, when paired with a reduced-calorie diet and increased physical activity.
Compounded medications are not FDA-approved and have not been evaluated in these trials; results for compounded products have not been clinically established. Individual results vary.
The process
Four steps. Less than a week.
Start your online visit
A short intake about your health and goals. A licensed provider reviews your profile within 24 hours — no waiting rooms, no forms to fax.
Meet your provider
Your provider builds a personalized treatment plan and prescribes the right medication. If you're not eligible, you're not charged.
Treatment, delivered
Medication ships discreetly from a US‑licensed pharmacy, fast and free. Take your first dose in less than a week.
Ongoing care
Message your provider anytime. Regular check‑ins, dose adjustments, and side‑effect support keep you on track for lasting results.
Treatments
Clinician-led care path
GLP-1 Injection
A GLP-1 medication that reduces appetite and slows digestion. Prepared on a per-patient basis when clinically indicated.
GLP-1 Tablet
A GLP-1 medication in oral form for patients who prefer not to inject.
Dual GIP / GLP-1 Injection
A dual-action GIP/GLP-1 medication that reduces appetite and slows digestion. Prepared on a per-patient basis when clinically indicated.
Background
What is semaglutide?+
Semaglutide is a GLP-1 receptor agonist — a class of medications that mimic a hormone the body naturally releases after eating. It reduces appetite and slows gastric emptying, which can help patients eat less and feel full longer.
FDA-approved formulations of semaglutide include Wegovy® (Novo Nordisk A/S), indicated for chronic weight management, and Ozempic® (Novo Nordisk A/S), indicated for type 2 diabetes. Pallas's compounded semaglutide is not FDA-approved, is not a generic version of Wegovy® or Ozempic®, and has not been evaluated by the FDA for safety, efficacy, or quality.
What is tirzepatide?+
Tirzepatide is a dual GIP/GLP-1 receptor agonist — it activates two gut-hormone receptors (GIP and GLP-1) rather than one. Like semaglutide, it reduces appetite and slows gastric emptying.
FDA-approved formulations of tirzepatide include Zepbound® (Eli Lilly and Company), indicated for chronic weight management, and Mounjaro® (Eli Lilly and Company), indicated for type 2 diabetes. Pallas's compounded tirzepatide is not FDA-approved, is not a generic version of Zepbound® or Mounjaro®, and has not been evaluated by the FDA for safety, efficacy, or quality.
Disclosures
Compounded medications are prepared by US-licensed compounding pharmacies on a per-patient basis when a licensed provider determines they are clinically appropriate. 503A pharmacies are licensed and inspected by state boards of pharmacy; 503B outsourcing facilities are registered with and inspected by the FDA and operate under current Good Manufacturing Practice (cGMP) standards. While these facilities are subject to regulatory oversight, the compounded medications themselves are not FDA-approved, are not generic versions of brand-name drugs, and have not been evaluated by the FDA for safety, efficacy, or quality. Treatment requires clinical eligibility and is at the discretion of the prescribing provider. Wegovy®, Ozempic®, Rybelsus®, and Saxenda® are registered trademarks of Novo Nordisk A/S. Zepbound®, Mounjaro®, and Trulicity® are registered trademarks of Eli Lilly and Company. These brand and product names are referenced above only to identify the FDA-approved class of medication; the respective trademark owners are not affiliated with, sponsors of, or endorsers of Pallas Health.
Pricing
One price. Everything included.
No hidden fees, no surprise charges. Membership includes provider care, medication, and ongoing support — shipped free.
Compounded semaglutide · Most popular
$179first month
Renews at $299/mo · Oral semaglutide from $319, tirzepatide from $229
- Licensed provider visits and follow-ups
- Medication shipped from US pharmacies
- Unlimited messaging with your care team
- Dose adjustments and side-effect support
- Cancel anytime — no long-term commitment
Your care team
“Weight management sits at the crossroads of family medicine, obesity medicine, and habit change.” Our clinicians are trained for the whole picture.
Dr. Ana Lisa Carr · Advising Physician
Board-certified family medicine, obesity medicine, addiction medicine · Licensed in all 50 states
Members · 4.9 / 5 from 2,400+ reviews
“I've tried everything — keto, intermittent fasting, every diet you can name. With Pallas, I finally feel like my body is working with me, not against me. Down 34 lbs.”
Bob M.
Member, 8 months
“The food noise is just… gone. For the first time in my life I can walk past the pantry without thinking about snacking.”
Sarah K.
Member, 7 months
“My provider answered every question, my medication arrived in four days, and I've lost 28 lbs without feeling deprived.”
David R.
Member, 6 months
“Real doctors, real prescriptions, real results. I'm down 22 lbs and my energy is through the roof.”
Christine T.
Member, 5 months
Common questions
Everything you need to know.
Answers on how Pallas works, what's included, and what to expect from treatment.
Complete a short health questionnaire, get matched with a US-licensed provider who reviews your information and (where clinically appropriate) writes a prescription, and receive medication shipped directly from a US-licensed pharmacy. The entire process is online — no office visits required.
Get started
Take the first step.
Match with a licensed provider today. If you're not eligible, you won't be charged.